<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Riverside Med.Practice</h1>
        This is some intro text.

        <h2>Prescribing where Riverside Med.Practice is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1104020Y0&amp;denomIds=11.4.2&amp;selectedTab=summary">Ketotifen fumarate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Other anti-inflammatory preparations</td>
      <td>36</td>
      <td>0.25</td>
      <td>0.02</td>
      <td>0.04</td>
      <td>6.48</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1104020Y0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Ketotifen 250micrograms/ml eye drops : 9</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0307000Q0&amp;denomIds=3.7&amp;selectedTab=summary">Erdosteine</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>14</td>
      <td>Mucolytics</td>
      <td>241</td>
      <td>0.06</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>4.93</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0307000Q0AAAAAA&amp;denomIds=3.7&amp;selectedTab=summary" target="_blank">Erdosteine 300mg capsules : 14</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0604012W0&amp;denomIds=6.4.1&amp;selectedTab=summary">Dienogest</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Progestogens and progesterone receptor modulators</td>
      <td>74</td>
      <td>0.05</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>4.85</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0604012W0AAAAAA&amp;denomIds=6.4.1&amp;selectedTab=summary" target="_blank">Dienogest 2mg tablets : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1307000K0&amp;denomIds=13.7&amp;selectedTab=summary">Podophyllotoxin</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Preparations for warts and calluses</td>
      <td>5</td>
      <td>0.60</td>
      <td>0.05</td>
      <td>0.14</td>
      <td>4.03</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1307000K0AAAAAA&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Podophyllotoxin 0.5% solution : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1307000K0BBACAB&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Warticon 0.15% cream : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1304000Y0&amp;denomIds=13.4&amp;selectedTab=summary">Mometasone furoate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>143</td>
      <td>Topical corticosteroids</td>
      <td>593</td>
      <td>0.24</td>
      <td>0.07</td>
      <td>0.04</td>
      <td>3.94</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1304000Y0AAAAAA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Mometasone 0.1% cream : 29</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1304000Y0AABABA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Mometasone 0.1% ointment : 110</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1304000Y0AABBBB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Mometasone 0.1% scalp lotion : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1304000Y0BBABBA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Elocon 0.1% ointment : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1304000Y0BBACBB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Elocon 0.1% scalp lotion : 1</a></div></td></tr></tbody></table>

        <h2>Prescribing where Riverside Med.Practice is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=1310040Q0&amp;denomIds=13.10.4&amp;selectedTab=summary">Permethrin</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Parasiticidal preparations</td>
      <td>2</td>
      <td>0.00</td>
      <td>0.84</td>
      <td>0.25</td>
      <td>-3.31</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0408020W0&amp;denomIds=4.8.2&amp;selectedTab=summary">Midazolam hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Drugs used in status epilepticus</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.79</td>
      <td>0.30</td>
      <td>-2.63</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0501090R0&amp;denomIds=5.1.9&amp;selectedTab=summary">Rifampicin</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Antituberculosis drugs</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.40</td>
      <td>-1.81</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0301030S0&amp;denomIds=3.1.3&amp;selectedTab=summary">Theophylline</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>11</td>
      <td>Theophylline</td>
      <td>27</td>
      <td>0.41</td>
      <td>0.83</td>
      <td>0.25</td>
      <td>-1.72</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGaElEQVR4nO3dXYwdYxzH8e/0VVtKW8pNmZAiGpoQpKVIhKQmkXBDE4JUcEMiJB1uXHjJiAgJkhKkxJUbLgw3pEhEvTWCuGhJxsuN6tJW9WW39XfxPCe7e3p2e3bPOTPz7Pw+yZOZ3Zw959ft+e2ZmfPMnMjMEJFmmFV1ABEpjwov0iAqvEiDqPAiDaLCizSICi/SICq8SIOo8CINosKLNIgKL9IgKnwIokjzn6Uv5lQdQEQmFqf5WcAm4DJgCPixyJIHp3t/KrxIDcVpHgFPArcAzwIZsARY38v9RjpbLgBRZJhFVceQcsRpPht4GTgZuK3IksP9um/tw4vUSJzms4A3gdnAhn6WHbRJL1I3jwDzgduLLPmv33euwovURJzm63H77GsHUXbQPnwYtA8/48VpHgNbgeuLLNk5qMfRPrxIxeI0nwO8BWwaZNlBhRepg0eBHUWWvD3oB9I+vEiF4jRfA2wALi3j8VR4kYrEab4Y2IJ7r31/GY+pTXqR6rwEbCmy5KuyHlCv8CIViNP8NmAFcGeZj6u35UKgt+VmlDjNVwHvAeuKLPm9zMfWJr1IieI0Pwl4G7i77LKDCi9SGj9PfgvwVpElH1WRQYUXKYE/3fU54CDwdFU5dNBOpBwPAauAGwY1T74bKrzIgMVp/jDupJhriywZrjKLCi8yIH4z/nHgSlzZ91UcSYUXGYQ4zU8GXgXmAuuLLDlYcSRAB+1E+s7Pj/8C+BK4uS5lB73Ci/RNnObLcRebvAS4q8iSzyuOdAwVXqRHcZqvwB2Fvwn31tu9RZaMVJuqMxVeZBriNF+Eu2T0ncD5wIvABUWW/FtlruPRXPoQaC59LcRpvhK4wY9VwEe4K8xurfK99alQ4UOgwpcuTvMFwMXA5X5cBuwG3vfj6yJLjlaXcHpU+BCo8AMVp/lC3Cv2RYyW/HRgO+5o+zZcwSt/H71XKnwIVPi+iNN8HnA2cB5wIa7gq4EFwA/Ad8C3uIL/UmTJjCuHCh8CFb5r/mDaCuBM4BzgXD/OwxX7Z2AHrtzfAd8XWTJUTdryqfAhaHjh4zSfDywDTvXjtDHrZ+AKvgJYDhwAfvOjVe4dwM4iS/aWHr5mVPgQzKDC+w9KXIor69gStxe5NRYCw7gDZruBP8es7wb+YLTgf4ZytLwqKnwIalp4/wEKSxlf3MnWTwKOAn8xWtghji1xq9hDRZYcKO9fNPOp8CHoc+H9q+zCDmMRsBj3McWtcUqHr5cBJ9K5vJOt75+JB8JC0tNMuzjN1wFHgEO4K3kcAvYDe4osOdJ7vPD4UyLnAvNwnwI6djnR+tzJRuHu97Hj3a5tzMcdpBpb6Nk+5lHcvm6nsQ/YC+zxy1/9cuxQeQPV69Ta+3FPogXACX55IrDEb+4dwL0CtI+htq//BkZwT8T//LI1zOec65dTXW+Vb94A1luFbTcCHMbte7aWwxN8b9jffrIBsKuL240dw8C/jBb5YFP/CMuogW7S+9lKSycZy/xyCa5Es3B/QMaOCPcEPuLHSNtysvUjjC9Vt+vd3vYwMDLwA0U13YeX8PRU+CiK7jGzV/qYZ6BCywvhZQ4tL4SXuZe8vV4A454ef75soeWF8DKHlhfCyzztvLrijUiDqPAiDdJr4YPZ7/FCywvhZQ4tL4SXedp5NfFGpEG0SS/SIFOaeBNF0VXAWmCXmb0eRdHNuFMQfzKzdwYRsFcdMt+Bu9jBB2a2tdp0x2rP67+3GdhiZtsqDTeBDr/jdcAaYJuZfVptumN1yLsRN88fM3u+0nATiKLoGuA+M7vVf70Rd5GOT8zss27vZ6qv8GvMLMOd1QSw0syewZ1vXFfjMpvZG8Bm3IUQ6mhcXv9H9eNKEx1f+/PiRtxU67qeudaedzauPLuqizQ5M/sYd3GOllPN7Cncp9p0baqFb9/hD+EAwLiMURQtAjbiLj5YR+2/04tw/6lXVJClW+2ZF5vZC8D1VYTpQnveWWb2CG5rNRTT6t6UDtr5TaE1uPnv24GzcL+knWb27nQCDFqHzA8APwEfmlntPiigPa+ZfeM35w7VfJO+/XkRA3vN7LUKo3XUIe/VuCnc/9R1xl0URauBJ3CX33oTuA63VfLpVDbpdZRepEF0lF6kQVR4kQZR4UUaRIUXaRAVXqRBVHiRBlHhRRpEhRdpEBVepEFUeJEGUeFFGuR/iyF861RvTOoAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0301030S0BKABAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 200mg tablets : 11</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>70</td>
      <td>Aminosalicylates</td>
      <td>180</td>
      <td>0.39</td>
      <td>0.64</td>
      <td>0.15</td>
      <td>-1.71</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0AAALAL&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 2g/59ml enema : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0AAANAN&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g modified-release granules sachets sugar free : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0AAARAR&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1.2g gastro-resistant modified-release tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0AAATAT&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 2g modified-release granules sachets sugar free : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0BCACAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 500mg modified-release tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0AAAHAH&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 250mg gastro-resistant tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0BBAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 400mg MR gastro-resistant tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0BBAFAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 800mg MR gastro-resistant tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0BCAAAC&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa Mesalazine 1g/100ml enema : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0BCADAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g suppositories : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0BIABAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 400mg MR gastro-resistant tablets : 21</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0AAAJAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g suppositories : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M82006&amp;numIds=0105010B0BDAJAW&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg gastro-resistant tablets : 5</a></div></td></tr></tbody></table>
        <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
        <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
    </div>

</body>

</html>